I'm considering investing in amam stock, but I'm not sure if it's a good decision. I want to know if buying this stock is a wise move based on its current performance and future prospects.
5 answers
Emanuele
Tue Nov 12 2024
The highest analyst price target for the stock is set at $28.01.
CryptoTitanGuard
Tue Nov 12 2024
Conversely, the lowest forecast also aligns with this figure, indicating a lack of significant divergence in opinions among analysts.
BitcoinBaroness
Tue Nov 12 2024
The average price target remains unchanged, reflecting a 0.00% increase from the current trading price of $21.
Isabella
Tue Nov 12 2024
Ambrx Biopharma has received a consensus analyst rating of Hold.
CherryBlossomFalling
Mon Nov 11 2024
This rating is based on the collective opinions of five Wall Street analysts, each providing their assessment of the company's future performance.